AETHLON MEDICAL INC (AEMD) Form 10-Q — Aug 13, 2026
Aethlon Medical filed its 10-Q for the quarter ended June 30, 2026, reporting no revenue and a net loss of $1.55 million, a 12% improvement from the $1.76 million loss in the year-ago quarter, as operating expenses fell 11.9% to $1.58 million on lower professional fees and G&A costs. Cash stood at $4.93 million at June 30, 2026 with working capital of $4.57 million. The company sold roughly $1.9 million gross of stock under its ATM program during the quarter and completed a ~$4.0 million registered offering in July 2026, which management says will fund planned operations for at least twelve months.
Key figures
- Revenue
- 0
- Total Assets
- 6235371
- Cash Position
- 4933579
- Rd expense
- 549000
- Working capital
- 4574872
- Atm net proceeds
- 1821000
- Atm gross proceeds
- 1904000
- Operating expenses
- 1579202
- Accumulated deficit
- 176654198
- Net loss yoy change
- -12.1% (narrowed by $213,946)
- Reverse split ratio
- 1-for-5
- Warrants outstanding
- 391500
- Operating expense yoy change
- -11.9%
- Shares outstanding june 30 2026
- 477402
- July 2026 offering gross proceeds
- 4000000
- Shares outstanding august 10 2026
- 711136
- Warrant weighted avg exercise price
- 32.38
Price after filing
Close on the filing date to close N calendar days later (from $2.93). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.